Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
Open-label Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System (Interstitial Multiple Diode Lasers and IDOSE® Software) and Verteporfin for Injection (VFI) for the Treatment of Recurrent Prostate Cancer

The rationale for the study is to obtain safety data as well as to establish dose parameters for the SpectraCure P18 System with IDOSE®, with verteporfin for injection (VFI) as photosensitizer for the treatment of recurrent prostate cancer.

  • 518 views
  • 11 Oct, 2022
  • 3 locations
Neoadjuvant Therapy Followed by Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic Cancer

The purpose of this study is to evaluate a new treatment routine for patients with borderline resectable and unresectable pancreas cancers.

gemcitabine
adenocarcinoma
karnofsky performance status
measurable disease
paclitaxel
  • 9 views
  • 08 Nov, 2020
  • 1 location
Routine Health Care of Patients With FSHD (FSHD)

On the basis of published data and our results indicating that oxidative stress may contribute to the peripheral skeletal muscle dysfunction in patients with FSHD, investigators conducted a pilot randomized double-blind placebo controlled trial to test whether oral administration of vitamins and mineral could improve the physical performance of patients …

  • 1 views
  • 17 Mar, 2022
  • 1 location
The Impact of Culinary Medicine vs. Nutrition Education on Diabetes Outcomes: A Randomized Trial

This pragmatic trial compares the effectiveness of virtual culinary medicine classes vs. standard of care medical nutrition visits to improve glycemic control in patients with uncontrolled type 2 diabetes . Culinary medicine teaches healthy eating principles through a combination of experiential cooking classes and focused didactic sessions. The primary study …

Accepts healthy volunteers
  • 0 views
  • 21 Oct, 2022
  • 1 location
Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

This is a randomized, open-label, controlled, multicenter, phase III trial to compare the efficacy and safety of Toripalimab in combination with axitinib to sunitinib monotherapy as a first-line therapy for advanced RCC. Eligible patients will be randomized 1:1 to receive the combination therapy of Toripalimab and axitinib or sunitinib monotherapy.

  • 2 views
  • 05 Feb, 2021
  • 1 location
Immunosuppressant Combined With Pirfenidone in CTD-ILD

36 months.The main research endpoints are lung function, patient dyspnea score, 6-minute walking distance, imaging indicators, primary disease activity, adverse reactions, etc.

dyspnea
immunosuppressive
rheumatism
progressive systemic sclerosis
pirfenidone
  • 2 views
  • 24 Jun, 2021
  • 1 location
Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease (GVHD)

response Estimate the incidence of primary disease relapse while on study treatment Estimate the incidence of infections including viral reactivation, bacterial infections and fungal

  • 0 views
  • 13 May, 2022
  • 2 locations
Keto-Brain: Investigating the Use of Ketogenic Diets in Brain Metastases

This pilot study will be a single center, randomized controlled study of 24 participants with diagnosed BM (various primary disease sites) comparing the effect of a ketogenic (n=12) and AICR (n

  • 0 views
  • 12 Oct, 2022
  • 1 location
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study (ReSOLVE_France)

The overall aim of this study is to hasten drug development for facioscapulohumeral muscular dystrophy (FSHD). Recent breakthroughs in FSHD research have identified the primary disease mechanism

facioscapulohumeral muscular dystrophy
diagnostic technique
arsenal
weakness
  • 0 views
  • 28 Oct, 2022
  • 2 locations
Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment

Recent numbers display a 85% survival-rate in children after a very harmful disease such as cancer. However, the survivors still experience mild to severe side effects of the primary disease or

  • 0 views
  • 15 Mar, 2022
  • 1 location